Olanzapine-Induced Clinical Seizure: A Case Report

被引:7
作者
Behere, Rishikesh V. [1 ]
Anjith, Divakaran [1 ]
Rao, Naren P. [1 ]
Venkatasubramanian, Ganesan [1 ]
Gangadhar, Bangalore N. [1 ]
机构
[1] Natl Inst Mental Hlth & Neurosci, Dept Psychiat, Metab Clin, Bangalore 560029, Karnataka, India
关键词
olanzapine; seizures; ATYPICAL ANTIPSYCHOTICS; EEG ABNORMALITIES; SCHIZOPHRENIA;
D O I
10.1097/WNF.0b013e3181a7fd00
中图分类号
R74 [神经病学与精神病学];
学科分类号
100204 [神经病学];
摘要
Atypical antipsychotics are known to be associated with electroencephalogram abnormalities. Olanzapine can lower seizure threshold and induce epileptiform discharges. However in patients on olanzapine for the treatment of a primary psychiatric disorder, clinical seizure is a rare occurence. We report the case of a 25-year-old man with a diagnosis of paranoid schizophrenia with obsessive-compulsive disorder of 8 years' duration who developed new-onset generalized tonic-clonic seizure with exposure to olanzapine. Electroencephalogram showed epileptiform discharges; results of computed tomographic scan and metabolic investigations were normal. His antipsychotic was changed to haloperidol, and the patient showed a significant improvement in psychotic symptoms with no recurrence of seizures and did not require anticonvulsant therapy. Olanzapine has a profile similar to that of clozapine and shares its seizure-inducing potential. Typical antipsychotics such as haloperidol might be a safer option for such patients.
引用
收藏
页码:297 / 298
页数:2
相关论文
共 12 条
[1]
Seizure incidence in psychopharmacological clinical trials: An analysis of food and drug administration (FDA) summary basis of approval reports [J].
Alper, Kenneth ;
Schwartz, Kelly A. ;
Kolts, Russell L. ;
Khan, Arif .
BIOLOGICAL PSYCHIATRY, 2007, 62 (04) :345-354
[2]
EEG abnormalities associated with antipsychotics: a comparison of quetiapine, olanzapine, haloperidol and healthy subjects [J].
Amann, BL ;
Pogarell, O ;
Mergl, R ;
Juckel, G ;
Grunze, H ;
Mulert, C ;
Hegerl, U .
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2003, 18 (08) :641-646
[3]
Bonelli RM, 2003, ANN PHARMACOTHER, V37, P149
[4]
Olanzapine-induced myodonic status [J].
Camacho, A ;
García-Navarro, M ;
Martínez, B ;
Villarejo, A ;
Pomares, E .
CLINICAL NEUROPHARMACOLOGY, 2005, 28 (03) :145-147
[5]
EEG abnormalities during treatment with typical and atypical Antipsychotics [J].
Centorrino, F ;
Price, BH ;
Tuttle, M ;
Bahk, WM ;
Hennen, J ;
Albert, MJ ;
Baldessarini, RJ .
AMERICAN JOURNAL OF PSYCHIATRY, 2002, 159 (01) :109-115
[6]
Dose response and atypical antipsychotics in schizophrenia [J].
Kinon, BJ ;
Ahl, J ;
Stauffer, VL ;
Hill, AL ;
Buckley, PF .
CNS DRUGS, 2004, 18 (09) :597-616
[7]
Seizure associated with olanzapine [J].
Lee, JW ;
Crismon, ML ;
Dorson, PG .
ANNALS OF PHARMACOTHERAPY, 1999, 33 (05) :554-556
[8]
A METHOD FOR ESTIMATING THE PROBABILITY OF ADVERSE DRUG-REACTIONS [J].
NARANJO, CA ;
BUSTO, U ;
SELLERS, EM ;
SANDOR, P ;
RUIZ, I ;
ROBERTS, EA ;
JANECEK, E ;
DOMECQ, C ;
GREENBLATT, DJ .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1981, 30 (02) :239-245
[9]
Raju GVL, 2000, CAN J PSYCHIAT, V45, P491
[10]
Schuld A, 2000, PHARMACOPSYCHIATRY, V33, P109